Literature DB >> 21471825

Effect modification of obesity on associations between endogenous steroid sex hormones and arterial calcification in women at midlife.

Samar R El Khoudary1, Rachel P Wildman, Karen Matthews, Lynda Powell, Steven M Hollenberg, Daniel Edmundowicz, Kim Sutton-Tyrrell.   

Abstract

OBJECTIVE: The aim of this study was to examine whether obesity modifies the effects of endogenous steroid sex hormones on arterial calcification in women at midlife.
METHODS: Associations between estradiol, testosterone, sex hormone-binding globulin, and free androgen index and the presence and extent of coronary and aortic calcification were evaluated in 187 obese (body mass index, ≥30 kg/m) and 281 nonobese (body mass index, <30 kg/m) women from the Study of Women's Health Across the Nation. Logistic and linear regressions were used as appropriate.
RESULTS: Prevalence rates of coronary and aortic calcification were significantly higher among obese compared with nonobese women (P < 0.001, for both). In multivariable analyses, steroid sex hormones were not associated with the presence of coronary calcification. However, for the extent of coronary calcification, significant interactions were found between obesity and both sex hormone-binding globulin (P < 0.0001) and free androgen index (P = 0.008). In nonobese women, higher sex hormone-binding globulin (P = 0.0006) and lower free androgen index (P = 0.01) were associated with a greater extent of coronary calcification, whereas lower sex hormone-binding globulin was associated with greater extent of coronary calcification in obese women (P = 0.05). For aortic calcification outcomes, higher sex hormone-binding globulin was associated with the presence of aortic calcification among nonobese women (odds ratio, 1.64; 95% CI, 1.16-2.32, for each 1-SD greater sex hormone-binding globulin).
CONCLUSIONS: Associations between endogenous steroid sex hormones and arterial calcification vary by obesity status among perimenopausal women. Further research is needed to better understand the possible mechanisms of these associations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21471825      PMCID: PMC3181045          DOI: 10.1097/gme.0b013e3182099dd2

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  41 in total

1.  Predictors of an increased risk of future hypertension in Utah. A screening analysis.

Authors:  S C Hunt; S H Stephenson; P N Hopkins; R R Williams
Journal:  Hypertension       Date:  1991-06       Impact factor: 10.190

2.  Quantification of coronary artery calcium using ultrafast computed tomography.

Authors:  A S Agatston; W R Janowitz; F J Hildner; N R Zusmer; M Viamonte; R Detrano
Journal:  J Am Coll Cardiol       Date:  1990-03-15       Impact factor: 24.094

3.  Development and evaluation of a method for quantitation of plasma high-density-lipoprotein cholesterol.

Authors:  E A Stein; P M Steiner; P S Gartside; C J Glueck
Journal:  Clin Chem       Date:  1978-07       Impact factor: 8.327

Review 4.  Sex hormone binding globulin: origin, function and clinical significance.

Authors:  C Selby
Journal:  Ann Clin Biochem       Date:  1990-11       Impact factor: 2.057

5.  Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women.

Authors:  S A Kaye; A R Folsom; J T Soler; R J Prineas; J D Potter
Journal:  Int J Epidemiol       Date:  1991-03       Impact factor: 7.196

6.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

7.  Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland.

Authors:  P Jousilahti; J Tuomilehto; E Vartiainen; J Pekkanen; P Puska
Journal:  Circulation       Date:  1996-04-01       Impact factor: 29.690

8.  Serum estrone concentrations and coronary artery disease in postmenopausal women.

Authors:  J A Cauley; J P Gutai; N W Glynn; M Paternostro-Bayles; E Cottington; L H Kuller
Journal:  Arterioscler Thromb       Date:  1994-01

9.  Increased upper body and overall adiposity is associated with decreased sex hormone binding globulin in postmenopausal women.

Authors:  S M Haffner; M S Katz; J F Dunn
Journal:  Int J Obes       Date:  1991-07

10.  Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range.

Authors:  W C Willett; J E Manson; M J Stampfer; G A Colditz; B Rosner; F E Speizer; C H Hennekens
Journal:  JAMA       Date:  1995-02-08       Impact factor: 56.272

View more
  4 in total

1.  Sex, Adiposity, and Hypertension Status Modify the Inverse Effect of Marine Food Intake on Blood Pressure in Alaska Native (Yup'ik) People.

Authors:  Brendin R Beaulieu-Jones; Diane M O'Brien; Scarlett E Hopkins; Jason H Moore; Bert B Boyer; Diane Gilbert-Diamond
Journal:  J Nutr       Date:  2015-03-18       Impact factor: 4.798

2.  Androgens, Irregular Menses, and Risk of Diabetes and Coronary Artery Calcification in the Diabetes Prevention Program.

Authors:  Catherine Kim; Vanita R Aroda; Ronald B Goldberg; Naji Younes; Sharon L Edelstein; MaryLou Carrion-Petersen; David A Ehrmann
Journal:  J Clin Endocrinol Metab       Date:  2018-02-01       Impact factor: 5.958

3.  Lipoprotein subfractions and subclinical vascular health in middle aged women: does menopause status matter?

Authors:  Meiyuzhen Qi; Xirun Chen; Ronald M Krauss; Karen Matthews; Imke Janssen; Maria M Brooks; Dan McConnell; Sybil L Crawford; Samar R El Khoudary
Journal:  Menopause       Date:  2022-07-12       Impact factor: 3.310

4.  Endogenous sex hormones impact the progression of subclinical atherosclerosis in women during the menopausal transition.

Authors:  Samar R El Khoudary; Rachel P Wildman; Karen Matthews; Rebecca C Thurston; Joyce T Bromberger; Kim Sutton-Tyrrell
Journal:  Atherosclerosis       Date:  2012-08-18       Impact factor: 5.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.